In this edition, nearly $1 million in grants to aid diversity, equity, inclusion research; topical halcinonide may benefit patients with psoriasis; Asian patients may experience earlier mycosis fungoides diagnosis and more.
Read the full coverage here:
Nearly $1 million in grants to aid dermatology research in diversity, equity, inclusion
Topical halcinonide may benefit patients with psoriasis with inadequate biologics response
Asian patients may experience earlier mycosis fungoides diagnosis, better outcomes
COVID-19 pandemic led to delayed melanoma diagnoses, more advanced tumors
Dupilumab use correlates with S. aureus reductions, atopic dermatitis improvements
References:
Bagel J, et al. J Drugs Dermatol. 2023;doi:10.36849/JDD.6830.
Chen Z, et al. JAMA Dermatol. 2023;doi:10.1001/jamadermatol.2023.2634.
Press Release
Simpson EL, et al. J Allergy Clin Immunol. 2023;doi:10.1016/j.jaci.2023.05.026.
Xiong D, et al. J Am Acad Dermatol. 2023;doi:10.1016/j.jaad.2023.08.040.
